Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1T7HJ | ISIN: US37427X1046 | Ticker-Symbol: GTN0
Siehe auch GETINGE AB
Frankfurt
21.11.24
08:19 Uhr
14,000 Euro
-0,500
-3,45 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
GETINGE AB ADR Chart 1 Jahr
5-Tage-Chart
GETINGE AB ADR 5-Tage-Chart

Aktuelle News zur GETINGE AB ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrFDA Highlights Safety Concerns & Class I Recall for Getinge's Vasoview Hemopro Devices16
11.11.Getinge Announces Official Cybersecurity Clearance From the US Defense Health Agency for Servo Ventilators8
07.11.Alexandra Holland appointed as EVP Communications at Getinge3
06.11.GETINGE: Contributing to a legacy of life-saving technology4
28.10.GETINGE: Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system7
18.10.Telefonkonferenz: Getinge meldet 10% Auftragswachstum, stagnierende organische Umsätze im dritten Quartal22
18.10.Earnings call: Getinge reports 10% order growth, flat organic sales in Q33
18.10.Getinge AB (publ) reports Q3 results14
GETINGE AB ADR Aktie jetzt für 0€ handeln
18.10.Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings157GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President...
► Artikel lesen
11.10.Research and Markets: Europe Dental Infections Control Market Analysis and Forecast to 2033, Featuring Profiles of Key Players Steris, Getinge, BMS Dental, Coltene Group, ASA Dental and Tuttnauer - ResearchAndMarkets.com416The "Europe Dental Infections Control Market: Focus on Offering, End User, and Country Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The European...
► Artikel lesen
09.10.FleetView by Getinge elevates service with connected devices5
04.10.Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call14
25.09.Getinge's CE certificate for ECLS consumables reinstated19
23.09.Getinge partners with MEDITECH on Talis Clinical solutions to enhance anesthesia management4
11.09.Signet Healthcare Partners Completes Sale of Paragonix Technologies to Getinge84NEW YORK--(BUSINESS WIRE)--Signet Healthcare Partners ("Signet") is pleased to announce that one of its medical device portfolio companies, Paragonix Technologies ("Paragonix" or the "Company")...
► Artikel lesen
11.09.Getinge completes $477M Paragonix acquisition3
11.09.Getinge completes the acquisition of Paragonix Technologies2
01.09.Getinge makes a provision of MBRL 240 related to Brazilian investigation3
26.08.Getinge enters transplant market, buying organ transport specialist Paragonix for $477M3
26.08.TransMedics stock rated a Buy amid Getinge acquisition5
Seite:  Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1